EXPERT REV VACCINES 润色咨询

Expert Review of Vaccines

出版年份:2002 年文章数:1031 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:5.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=821c2395, cover=https://img.medsci.cn/images/journal/cover/2021/ljz_202109271315020240.jpg, fullname=Expert Review of Vaccines, abbr=EXPERT REV VACCINES, pyear=2002, frequence=Bimonthly, articleNumbers=1031, citedSelf2015=5.0, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1476-0584, greenSci=https://www.greensci.net/search?kw=1476-0584, scijournal=https://www.scijournal.org/impact-factor-of-EXPERT-REV-VACCINES.shtml, medsciHotlightString=null, medsciHotlightRealtime=2.068, medsciHotlight=2.026, medsciHotlight5year=2.53655, citescore=8.2, hIndex=86, impactFactor=6.2, orgnization=Taylor and Francis Ltd., orgnizationUrl=http://www.future-drugs.com/, country=United Kingdom, countryCn=英国, isOa=3, isOaString=部分OA, sciScie=Science Citation Index Expanded|Current Contents - Clinical Medicine, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=https://www.tandfonline.com/toc/ierv20/current, websiteHits=5284, guideForAuthor=null, guideForAuthorHits=4, submitWebsite=https://mc.manuscriptcentral.com/ervx, submitWebsiteHits=1705, content=Published by Future-Drugs. ISSN: 1476-0584.<br /><br />The vaccine field has been transformed by the technological advances of the past decade. We are now beginning to visualize the future impact of vaccines, in terms of both healthcare and economics. Prophylactic vaccines continue to offer a revolution in quality of life, particularly among the populations of developing countries. Expansion of the field into the area of therapeutic vaccines is set to change radically the wider perception of vaccines in the healthcare and R&D communities. Rapid advances are anticipated with the prospect of therapeutic vaccines for the treatment of AIDS, cancer and other major diseases. There remain many challenges in the delivery of cost-effective, safe vaccines. Expert Review of Vaccines provides structured, informed commentary on the development and application of new vaccines and vaccine technologies, with all articles subject to rigorous peer-review., totalCites=6396, brief=EXPERT REV VACCINES杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=免疫学" >免疫学</a></strong>”子行业的偏低级别杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=EXPERT REV VACCINES杂志级别还可以,但是相对来说,比较冷门,关注人数偏少,有些可能是国内不太熟悉,但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿,稿源可能未必丰富,发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=821c2395'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=483514, tagName=疫苗相关临床研究, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=3.08), GetImpactFactorCiteScoreListResponse(year=2017, citescore=3.3), GetImpactFactorCiteScoreListResponse(year=2018, citescore=3.67), GetImpactFactorCiteScoreListResponse(year=2019, citescore=7.6), GetImpactFactorCiteScoreListResponse(year=2020, citescore=8.2)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=2.751), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=2.416), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=2.0), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=1.995), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=2.068)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Drug Discovery , rank=18/143), GetImpactFactorCiteScoreGradeResponse(smallClass=Molecular Medicine , rank=30/165), GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology , rank=34/301), GetImpactFactorCiteScoreGradeResponse(smallClass=Immunology , rank=46/200)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=IMMUNOLOGY - SCIE , rank=51/158)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1476-0584[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Expert Review of Vaccines[ta], article_number=179, article_number_cn=22, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
EXPERT REV VACCINES/Expert Review of Vaccines
ISSN
1476-0584
影响指数话题
预警等级
MedSci期刊指数
2.068 (MedSci实时期刊指数) | 2.53655 (5年期刊指数)
CiteScore值
8.2
h-index
86
h5-median
暂无数据
出版社/管理机构
杂志由 Taylor and Francis Ltd. 出版或管理
出版国家/地区
United Kingdom 英国
出版周期
Bimonthly
出版年份
2002
是否OA
部分OA
被收录情况
Science Citation Index Expanded|Current Contents - Clinical Medicine
JCR分区
IMMUNOLOGY - SCIE 51/158
中科院分区
大类:医学 2区
小类:医学 2 区